Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
NRXP holding history
NRX Pharmaceuticals, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRXP overviewAll 13F holders of NRXPFull Q4 2025 holdings
- Shares (Q4 2025)
- 729,842
- Value
- $1.98M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 729,842 | $1.98M | <0.1% | +194,886+36.4% | Added | Holders |
| Q3 2025 | 534,956 | $1.77M | <0.1% | +82,781+18.3% | Added | Holders |
| Q2 2025 | 452,175 | $1.47M | <0.1% | +63,250+16.3% | Added | Holders |
| Q1 2025 | 388,925 | $797.3K | <0.1% | +148,609+61.8% | Added | Holders |
| Q4 2024 | 240,316 | $528.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 240,316 | $406.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 240,316 | $586.4K | <0.1% | −1,199,729−83.3% | Reduced | Holders |
| Q1 2024 | 1,440,045 | $679.6K | <0.1% | −5,132−0.4% | Reduced | Holders |
| Q4 2023 | 1,445,177 | $664.8K | <0.1% | −5,416−0.4% | Reduced | Holders |
| Q3 2023 | 1,450,593 | $377.2K | <0.1% | −27,560−1.9% | Reduced | Holders |
| Q2 2023 | 1,478,153 | $714.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,478,153 | $974.3K | <0.1% | +34,990+2.4% | Added | Holders |
| Q4 2022 | 1,443,163 | $1.60M | <0.1% | +2,898+0.2% | Added | Holders |
| Q3 2022 | 1,440,265 | $1.06M | <0.1% | +345,552+31.6% | Added | Holders |
| Q2 2022 | 1,094,713 | $657.0K | <0.1% | +19,396+1.8% | Added | Holders |
| Q1 2022 | 1,075,317 | $2.63M | <0.1% | −96,916−8.3% | Reduced | Holders |
| Q4 2021 | 1,172,233 | $5.60M | <0.1% | +172,110+17.2% | Added | Holders |
| Q3 2021 | 1,000,123 | $9.27M | <0.1% | +362,707+56.9% | Added | Holders |
| Q2 2021 | 637,416 | $7.41M | <0.1% | +637,416 | New | Holders |